Presentation Information
[Pj-024-5]Backgrounds associated with cessation of oral prednisolone in the treatment of myasthenia gravis
Kazuo Iwasa1,2, Tokuhei Ikeda2, Hiroto Nakano2, Yasuhiro Sakashita2, Junji Komatsu2, Moeko Shinohara2, Kenjiro Ono2 (1.Deaprtment of Health and Medical Sciences, Ishikawa Prefectural Nursing University, Japan, 2.Department of Neurology, Kanazawa University Graduate School of Medical Sciences, Japan)